Hemorrhagic Stroke Surgical Quality Improvement Initiative

Stroke remains a leading cause of death and disability in the United States. Hemorrhagic strokes, which result from bleeding in the brain, account for a smaller portion of all strokes but are associated with significantly higher mortality rates compared to other types. 

Emerging treatments like minimally invasive parafascicular surgery (MIPS) offer new hope. Research shows that when performed early, MIPS can lead to better long-term recovery than standard treatment approaches.

Starting in 2025, the American Heart Association will lead a two-year initiative with Stryker as a proud supporter of the American Heart Association’s ICH Surgical Quality Improvement Initiative to improve intracerebral hemorrhage (ICH) care.

RESOURCES
Trial of Early Minimally Invasive Removal of Intracerebral Hemorrhage